Skip to main content

Table 4 Adjusted hazard ratios of diabetes incidence comparing individual angiotensin receptor blocker with losartan among different subgroups

From: Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study

 

Valsartan

Irbesartan

Candesartan

Telmisartan

Olmesartan

Age < 70 years

1.01 (0.99-1.04)

1.01 (0.98-1.04)

1.02 (0.98-1.06)

1.01 (0.97-1.05)

1.07 (1.02-1.12)

Age ≧ 70 years

1.00 (0.96-1.04)

0.95 (0.91-0.99)

0.92 (0.86-0.99)

0.95 (0.89-1.01)

1.09 (1.01-1.18)

Men

0.99 (0.97-1.02)

0.98 (0.95-1.01)

1.00 (0.95-1.05)

0.98 (0.94-1.03)

1.08 (1.02-1.14)

Women

1.03 (1.00-1.06)

1.01 (0.97-1.04)

0.99 (0.94-1.04)

1.00 (0.96-1.05)

1.06 (1.00-1.13)

With hypertension

1.01 (0.99-1.03)

0.98 (0.96-1.01)

0.99 (0.95-1.02)

0.98 (0.95-1.02)

1.07 (1.02-1.11)

Without hypertension

1.02 (0.96-1.08)

1.07 (0.99-1.15)

1.03 (0.93-1.14)

1.09 (0.97-1.22)

1.13 (0.98-1.31)